Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure

We have synthesized a number of novel bicyclic hexahydroaporphines containing a phenethylamine moiety for preliminary study as intraocular pressure lowering agents. The target molecules were synthesized in a twelve step process. The final products were secondary or tertiary amines containing either...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of ocular pharmacology and therapeutics 1997-12, Vol.13 (6), p.497-505
Hauptverfasser: SAHA, S. L, ZHAN, G, TANG, L, OPERE, C, ROCHE, E. B, CAMRAS, C. B, OHIA, S. E, ROCHE, V. F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 505
container_issue 6
container_start_page 497
container_title Journal of ocular pharmacology and therapeutics
container_volume 13
creator SAHA, S. L
ZHAN, G
TANG, L
OPERE, C
ROCHE, E. B
CAMRAS, C. B
OHIA, S. E
ROCHE, V. F
description We have synthesized a number of novel bicyclic hexahydroaporphines containing a phenethylamine moiety for preliminary study as intraocular pressure lowering agents. The target molecules were synthesized in a twelve step process. The final products were secondary or tertiary amines containing either an aromatic methoxy or phenolic substituent. These molecules, in hydrochloride salt form, were assayed in doses ranging from 0.1-1.5%. All products and vehicle were administered topically to one eye of normotensive rabbits and intraocular pressure was measured in both eyes for up to six hours. Four of the five compounds examined produced a significant and, in some cases, prolonged, ocular hypotensive response. Secondary and N-methylated tertiary amines were equally effective, as were compounds containing either the 10-methoxy group of free phenol. Studies are currently in progress to optimize potency and identify functional and molecular mechanisms of action.
doi_str_mv 10.1089/jop.1997.13.497
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79521221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79521221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-f218ad5301d7aa4ce699d13bca37ee7804242481268355541d57ce09277037f3</originalsourceid><addsrcrecordid>eNo9kE1P3DAQhi1UBJT2zAnJh4pbFo8dx3FvBfVLQu2FS0_W4ExYo2wc7GRh_329YoXmMCO9z4w0D2MXIFYgWnv9FKcVWGtWoFa1NUfsDLQ2lTFKfiizaEVlmladso85PwkBSjRwwk5srRrQ6oz9uwl-54fgeUcpbHEOW8o89nxNr7jedSniFNO0DiPxr_xP3NLA8ZHGOfN5jTMf4gslHsY5YfTLgIlPiXJeEn1ixz0OmT4f-jm7__H9_vZXdff35-_bb3eVVxLmqpfQYqeVgM4g1p4aaztQDx6VITKtqGWpFmT5QmtdQ6eNJ2GlMUKZXp2zq7ezU4rPC-XZbUL2NAw4UlyyM1ZLkBIKeP0G-hRzTtS7KYUNpp0D4fYuXXHp9i4dKFdclo3Lw-nlYUPdO3-QV_Ivhxyzx6FPOPqQ3zEJxXVTq_-p2Hz5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79521221</pqid></control><display><type>article</type><title>Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>SAHA, S. L ; ZHAN, G ; TANG, L ; OPERE, C ; ROCHE, E. B ; CAMRAS, C. B ; OHIA, S. E ; ROCHE, V. F</creator><creatorcontrib>SAHA, S. L ; ZHAN, G ; TANG, L ; OPERE, C ; ROCHE, E. B ; CAMRAS, C. B ; OHIA, S. E ; ROCHE, V. F</creatorcontrib><description>We have synthesized a number of novel bicyclic hexahydroaporphines containing a phenethylamine moiety for preliminary study as intraocular pressure lowering agents. The target molecules were synthesized in a twelve step process. The final products were secondary or tertiary amines containing either an aromatic methoxy or phenolic substituent. These molecules, in hydrochloride salt form, were assayed in doses ranging from 0.1-1.5%. All products and vehicle were administered topically to one eye of normotensive rabbits and intraocular pressure was measured in both eyes for up to six hours. Four of the five compounds examined produced a significant and, in some cases, prolonged, ocular hypotensive response. Secondary and N-methylated tertiary amines were equally effective, as were compounds containing either the 10-methoxy group of free phenol. Studies are currently in progress to optimize potency and identify functional and molecular mechanisms of action.</description><identifier>ISSN: 1080-7683</identifier><identifier>EISSN: 1557-7732</identifier><identifier>DOI: 10.1089/jop.1997.13.497</identifier><identifier>PMID: 9436153</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>Animals ; Aporphines - chemical synthesis ; Aporphines - pharmacology ; Biological and medical sciences ; Bridged Bicyclo Compounds - chemical synthesis ; Bridged Bicyclo Compounds - pharmacology ; Eye ; Eye - drug effects ; Female ; Intraocular Pressure - drug effects ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Rabbits</subject><ispartof>Journal of ocular pharmacology and therapeutics, 1997-12, Vol.13 (6), p.497-505</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c321t-f218ad5301d7aa4ce699d13bca37ee7804242481268355541d57ce09277037f3</citedby><cites>FETCH-LOGICAL-c321t-f218ad5301d7aa4ce699d13bca37ee7804242481268355541d57ce09277037f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3042,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2106164$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9436153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SAHA, S. L</creatorcontrib><creatorcontrib>ZHAN, G</creatorcontrib><creatorcontrib>TANG, L</creatorcontrib><creatorcontrib>OPERE, C</creatorcontrib><creatorcontrib>ROCHE, E. B</creatorcontrib><creatorcontrib>CAMRAS, C. B</creatorcontrib><creatorcontrib>OHIA, S. E</creatorcontrib><creatorcontrib>ROCHE, V. F</creatorcontrib><title>Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure</title><title>Journal of ocular pharmacology and therapeutics</title><addtitle>J Ocul Pharmacol Ther</addtitle><description>We have synthesized a number of novel bicyclic hexahydroaporphines containing a phenethylamine moiety for preliminary study as intraocular pressure lowering agents. The target molecules were synthesized in a twelve step process. The final products were secondary or tertiary amines containing either an aromatic methoxy or phenolic substituent. These molecules, in hydrochloride salt form, were assayed in doses ranging from 0.1-1.5%. All products and vehicle were administered topically to one eye of normotensive rabbits and intraocular pressure was measured in both eyes for up to six hours. Four of the five compounds examined produced a significant and, in some cases, prolonged, ocular hypotensive response. Secondary and N-methylated tertiary amines were equally effective, as were compounds containing either the 10-methoxy group of free phenol. Studies are currently in progress to optimize potency and identify functional and molecular mechanisms of action.</description><subject>Animals</subject><subject>Aporphines - chemical synthesis</subject><subject>Aporphines - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Bridged Bicyclo Compounds - chemical synthesis</subject><subject>Bridged Bicyclo Compounds - pharmacology</subject><subject>Eye</subject><subject>Eye - drug effects</subject><subject>Female</subject><subject>Intraocular Pressure - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Rabbits</subject><issn>1080-7683</issn><issn>1557-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1P3DAQhi1UBJT2zAnJh4pbFo8dx3FvBfVLQu2FS0_W4ExYo2wc7GRh_329YoXmMCO9z4w0D2MXIFYgWnv9FKcVWGtWoFa1NUfsDLQ2lTFKfiizaEVlmladso85PwkBSjRwwk5srRrQ6oz9uwl-54fgeUcpbHEOW8o89nxNr7jedSniFNO0DiPxr_xP3NLA8ZHGOfN5jTMf4gslHsY5YfTLgIlPiXJeEn1ixz0OmT4f-jm7__H9_vZXdff35-_bb3eVVxLmqpfQYqeVgM4g1p4aaztQDx6VITKtqGWpFmT5QmtdQ6eNJ2GlMUKZXp2zq7ezU4rPC-XZbUL2NAw4UlyyM1ZLkBIKeP0G-hRzTtS7KYUNpp0D4fYuXXHp9i4dKFdclo3Lw-nlYUPdO3-QV_Ivhxyzx6FPOPqQ3zEJxXVTq_-p2Hz5</recordid><startdate>19971201</startdate><enddate>19971201</enddate><creator>SAHA, S. L</creator><creator>ZHAN, G</creator><creator>TANG, L</creator><creator>OPERE, C</creator><creator>ROCHE, E. B</creator><creator>CAMRAS, C. B</creator><creator>OHIA, S. E</creator><creator>ROCHE, V. F</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19971201</creationdate><title>Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure</title><author>SAHA, S. L ; ZHAN, G ; TANG, L ; OPERE, C ; ROCHE, E. B ; CAMRAS, C. B ; OHIA, S. E ; ROCHE, V. F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-f218ad5301d7aa4ce699d13bca37ee7804242481268355541d57ce09277037f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Aporphines - chemical synthesis</topic><topic>Aporphines - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Bridged Bicyclo Compounds - chemical synthesis</topic><topic>Bridged Bicyclo Compounds - pharmacology</topic><topic>Eye</topic><topic>Eye - drug effects</topic><topic>Female</topic><topic>Intraocular Pressure - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Rabbits</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SAHA, S. L</creatorcontrib><creatorcontrib>ZHAN, G</creatorcontrib><creatorcontrib>TANG, L</creatorcontrib><creatorcontrib>OPERE, C</creatorcontrib><creatorcontrib>ROCHE, E. B</creatorcontrib><creatorcontrib>CAMRAS, C. B</creatorcontrib><creatorcontrib>OHIA, S. E</creatorcontrib><creatorcontrib>ROCHE, V. F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of ocular pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SAHA, S. L</au><au>ZHAN, G</au><au>TANG, L</au><au>OPERE, C</au><au>ROCHE, E. B</au><au>CAMRAS, C. B</au><au>OHIA, S. E</au><au>ROCHE, V. F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure</atitle><jtitle>Journal of ocular pharmacology and therapeutics</jtitle><addtitle>J Ocul Pharmacol Ther</addtitle><date>1997-12-01</date><risdate>1997</risdate><volume>13</volume><issue>6</issue><spage>497</spage><epage>505</epage><pages>497-505</pages><issn>1080-7683</issn><eissn>1557-7732</eissn><abstract>We have synthesized a number of novel bicyclic hexahydroaporphines containing a phenethylamine moiety for preliminary study as intraocular pressure lowering agents. The target molecules were synthesized in a twelve step process. The final products were secondary or tertiary amines containing either an aromatic methoxy or phenolic substituent. These molecules, in hydrochloride salt form, were assayed in doses ranging from 0.1-1.5%. All products and vehicle were administered topically to one eye of normotensive rabbits and intraocular pressure was measured in both eyes for up to six hours. Four of the five compounds examined produced a significant and, in some cases, prolonged, ocular hypotensive response. Secondary and N-methylated tertiary amines were equally effective, as were compounds containing either the 10-methoxy group of free phenol. Studies are currently in progress to optimize potency and identify functional and molecular mechanisms of action.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>9436153</pmid><doi>10.1089/jop.1997.13.497</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1080-7683
ispartof Journal of ocular pharmacology and therapeutics, 1997-12, Vol.13 (6), p.497-505
issn 1080-7683
1557-7732
language eng
recordid cdi_proquest_miscellaneous_79521221
source Mary Ann Liebert Online Subscription; MEDLINE
subjects Animals
Aporphines - chemical synthesis
Aporphines - pharmacology
Biological and medical sciences
Bridged Bicyclo Compounds - chemical synthesis
Bridged Bicyclo Compounds - pharmacology
Eye
Eye - drug effects
Female
Intraocular Pressure - drug effects
Male
Medical sciences
Pharmacology. Drug treatments
Rabbits
title Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A24%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bicyclic%20derivatives%20of%20hexahydroaporphine%20:%20Novel%20agents%20that%20lower%20intraocular%20pressure&rft.jtitle=Journal%20of%20ocular%20pharmacology%20and%20therapeutics&rft.au=SAHA,%20S.%20L&rft.date=1997-12-01&rft.volume=13&rft.issue=6&rft.spage=497&rft.epage=505&rft.pages=497-505&rft.issn=1080-7683&rft.eissn=1557-7732&rft_id=info:doi/10.1089/jop.1997.13.497&rft_dat=%3Cproquest_cross%3E79521221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79521221&rft_id=info:pmid/9436153&rfr_iscdi=true